Short answer
GE HealthCare (GEHC) filed an 8-K current report with the SEC on July 29, 2026 reporting Item EX-99.1 (Exhibit EX-99.1), Item 2.02 (Results of Operations and Financial Condition). GE HealthCare announced second-quarter 2026 financial results on July 29, 2026.
GE HealthCare 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- GE HealthCare announced second-quarter 2026 financial results on July 29, 2026
- Results details are contained in the furnished Exhibit 99 press release
Item EX-99.1 · Exhibit EX-99.1
- Q2 revenue $5.3B, up 5.7%, with organic growth 3.5%, supporting reaffirmed full-year growth guidance of 3.0%-4.0%
- Record organic orders growth 11.1%, book-to-bill 1.15x, and backlog $23.9B, signaling strong demand visibility
- AIS and PDx growth offset PCS deterioration: organic revenue up 5.0% and 14.6%, while PCS fell 13.5% with EBIT margin negative 3.8%
- Adjusted EBIT margin 14.2%, down 40 bps, despite $23M tariff refunds and approximately $250M expected inflation pressure
- Cash flow improved, with free cash flow $68M and $1.6B full-year target, while $200M share repurchases reduced shares outstanding
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other GE HealthCare 8-K filings
Get the next GEHC 8-K as it lands
Follow GEHC for push alerts, or ask the research agent what this filing means.